000 01516 a2200421 4500
005 20250514232755.0
264 0 _c20050915
008 200509s 0 0 eng d
022 _a0006-291X
024 7 _a10.1016/j.bbrc.2005.06.076
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLu, Jian-Xin
245 0 0 _aRational design of an EGF-IL18 fusion protein: implication for developing tumor therapeutics.
_h[electronic resource]
260 _bBiochemical and biophysical research communications
_cAug 2005
300 _a157-61 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aCarcinoma, Squamous Cell
_xgenetics
650 0 4 _aCell Line
650 0 4 _aDrug Delivery Systems
_xmethods
650 0 4 _aDrug Design
650 0 4 _aEpidermal Growth Factor
_xgenetics
650 0 4 _aErbB Receptors
_xmetabolism
650 0 4 _aGene Targeting
_xmethods
650 0 4 _aHumans
650 0 4 _aInterleukin-18
_xgenetics
650 0 4 _aProtein Engineering
_xmethods
650 0 4 _aRecombinant Fusion Proteins
_xmetabolism
650 0 4 _aSpodoptera
_xgenetics
650 0 4 _aTransfection
_xmethods
700 1 _aPeng, Ying
700 1 _aMeng, Zhe-Feng
700 1 _aJin, Li-Qin
700 1 _aLu, Yong-Sui
700 1 _aGuan, Min-Xin
773 0 _tBiochemical and biophysical research communications
_gvol. 334
_gno. 1
_gp. 157-61
856 4 0 _uhttps://doi.org/10.1016/j.bbrc.2005.06.076
_zAvailable from publisher's website
999 _c15650732
_d15650732